HPV early proteins E6 and E7 are the major viral oncoproteins that regulate cell proliferation through the inactivation of p53 and Rb1 tumour suppressor proteins respectively.
| Institute |
|---|
| University of Cambridge |
| Cat. #: | 151170 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Cancer types: | Gynaecologic cancer |
| Research Fields: | Cancer;Microbiology |
| Application: | ELISA ; FACS ; IHC ; IF ; WB |
| Target: | Human Papilloma Virus-16 early protein 7 (HPV16 E7) |
| Reactivity: | Human papilloma virus |
| Clone: | TVG 701Y |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Tommasino et al. 1993. Oncogene. 8(1):195-202. PMID: 8380917. |
| Alternate name: | Anti-Human Papillomavirus 16 (E7) antibody [TVG 701Y]; Anti-HPV16E7 [TVG 701Y]; HPV16 E7; Protein E7; E7; HPV antibody |
|---|---|
| Product description: | Tumour antigens are proteins found in tumour cells and recognised by cellular or humoral effectors of the immune system. Tumour antigens are useful in identifying cancer cells, they also can be leveraged as targets in cancer therapy. Anti-Human Papillomavirus 16 (E7) antibody [TVG 701Y] also known as Anti-HPV16E7 [TVG 701Y] is an antibody against a tumour-specific antigen (TSA). TSA's are restricted to tumours and are not found in healthy cells. Anti-HPV16E7 [TVG 701Y] is a monoclonal antibody against HPV16E7. The human papilloma virus (HPV) family of DNA tumour viruses includes HPV-16 and HPV-18. These are associated with a large proportion of cervical cancer cases. E7 is the major transforming protein of human papillomavirus type 16 (HPV16). The immunogen is HPV 16 E7 synthesised from S. pombe. |
| Conjugation: | Unconjugated |
| Isotype: | IgG2a |
| Molecular weight: | Antigen MW is 19KD |
| Immunogen: | HPV 16 E7 synthesised from S. pombe |
| Myeloma used: | P3/NS1/1-Ag4.1 |
| Target background: | The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases. HPV early proteins E6 and E7 are the major viral oncoproteins that regulate cell proliferation through the inactivation of p53 and Rb1 tumour suppressor proteins respectively. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | '-15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Chen et al. 2020. Antiviral Res. 178:104794. PMID: 32298665. Kannan et al. 2017. Sci Rep. 7:46102. PMID: 28383029. Harris et al. 2013. Br J Cancer. 108(4):859-865. PMID: 23385729. Tommasino et al. 1993. Oncogene. 8(1):195-202. PMID: 8380917. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.